Lutein & Zeaxanthin

Lutein and zeaxanthin are the carotenoids concentrated in the macula, and their evidence base is unusually good for a supplement: AREDS2, an NIH-funded, double-masked, placebo-controlled trial in 4203 people aged 50–85 followed for a median of 5 years. That is a better trial than almost anything else in this database has. The result, however, was negative on its primary endpoint: adding lutein + zeaxanthin to the AREDS formula did not significantly reduce progression to advanced AMD (HR 0.90, 98.7% CI 0.76–1.07, P=.12). The positive findings come from secondary and longer-term analyses — at 10 years, HR 0.91 (P=.02) versus no lutein/zeaxanthin, and 0.85 (P=.02) when compared directly against beta-carotene. A separate 2024 post-hoc analysis found slower progression of geographic atrophy toward the central macula. So: real signal, modest size, and confined to a population already at risk. The trial's clearest practical result was actually about safety — beta-carotene nearly doubled 10-year lung cancer risk in this cohort (OR 1.82) while lutein/zeaxanthin did not, which is why it replaced beta-carotene in the standard formula. Grade C: the evidence is genuinely good quality, but what it shows is a small effect in a specific patient group, not general protection of the aging eye.

Both are xanthophyll carotenoids that accumulate selectively in the macula, forming the macular pigment. There they absorb high-energy blue light and act as antioxidants in a tissue with extreme oxygen consumption and lifelong light exposure. The body cannot synthesise them — macular levels depend on diet or supplementation.

Well tolerated at trial doses (10 mg lutein + 2 mg zeaxanthin) over years, with no safety signal in AREDS2. High intake can cause carotenodermia, a harmless yellowing of the skin that reverses on stopping. The important safety lesson from this trial concerns a different carotenoid: beta-carotene nearly doubled lung cancer risk over 10 years, concentrated in former smokers. If you smoke or used to, avoid beta-carotene formulas specifically.

AREDS2 used 10 mg lutein + 2 mg zeaxanthin per day, and that pairing and ratio is what the evidence actually covers. Higher doses are marketed but were not what was tested. Dietary sources — kale, spinach, egg yolk — supply meaningful amounts, and absorption improves with fat in the same meal.